2,490 results found

Therapeutic applications of stem cells are central to the promise of regenerative medicine. An increasing number of stem cell therapies are being approved for clinical use and by some estimates

We are proud to announce a new podcast series with Louis-Pierre Gravelle of B&P in collaboration with ISEQ to demystify and explore the intellectual property (IP)...

On October 9, 2012, six retailers, BEST BUY, COSTCO, GAP, OLD NAVY, GUESS? and WAL-MART, filed a motion in the Superior Court of Québec seeking a declaratory judgement against the Office québécoise de la langue française (OQLF) that the use of their trademarks on signage, without a French descriptor, is compliant with the Charter of the French Language (the Charter) and its regulations.

On March 30, 2023, the Supreme Court of Canada dismissed Pharmascience's application for leave to appeal (Docket No. 40400) a decision of the Federal Court of Appeal (FCA) upholding the validity...

On November 30, 2018, Global Affairs Canada issued a news release announcing the signing of the Canada-United States-Mexico Agreement (CUSMA or USMCA) ...

On January 30, 2018, the Government of Canada posted the Comprehensive and Progressive Partnership for Trans-Pacific Partnership (CPTPP) - Backgrounder.

The US Federal Trade Commission is taking aim at native advertising and sponsored content.

On April 23, 2018, the Competition Bureau announced an agreement whereby Metro will sell properties/leases and take steps to terminate agreements relating to pharmacies in certain Quebec markets.

Crowdfunding has quickly become a popular method of raising capital on the Internet, and can lift small and medium-sized companies off the ground.

The Federal Government has published the following proposed amending regulations in Part 1 of the Canada Gazette...

On September 1, 2022, the Canadian Agency for Drugs and Technologies in Health (CADTH) announced the launch of its Post-Market Drug Evaluation Program.

CADTH proposals to enhance drug review processes.

Canada's Drug Agency has released new guidance on using artificial intelligence methods to generate real-world evidence for health technology assessments, establishing governance considerations and appraisal principles that emphasize transparency, human oversight, and validation. The agency also launched initiatives supporting precision medicine decision-making, including testing procedure assessments and a pan-Canadian framework for biomarker evaluation in cancer care.

The strategy, titled, "A Prescription for Action: A Pan-Canadian Strategy for Advancing the Appropriate Use of Prescription Medications" provides a 5-year plan to foster a unified national approach that promotes safer, more effective medication use and strengthens health system sustainability.

The Competition Bureau's investigation concluded that NuvoCare's weight loss claims were not supported by adequate and proper testing.

The Federal Court struck Novo Nordisk's judicial review application challenging the decision of the Minister of Health to accept for review an Abbreviated New Drug Submission (ANDS)

On April 24, 2019, the Federal Court of Appeal (FCA) affirmed the Federal Court's (FC) dismissal of Apotex's application for judicial review of a decision

The United States Food and Drug Administration (FDA) released Draft Guidance on February 9, 2012 for obtaining approval of subsequent-entry versions of biologic drugs (also known as biosimilars).